Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection

Journal of Controlled Release

Volumn 135, Issue 3, 2009, Pages 242-249

  Cheng, Jing Yan ^a,b   Huang, Hang Ning ^a   Tseng, Wen Chi ^c   Li, Tsung Lin ^d   Chan, Yi Lin ^b   Cheng, Kai Chun ^a   Wu, Chang Jer ^a  

^a NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

DNA vaccine; Japanese encephalitis virus; Langerhans cells; Lipoplex patch; Transcutaneous immunization

Indexed keywords

DNA VACCINE; JAPANESE ENCEPHALITIS VIRUS; LANGERHANS CELLS; LIPOPLEX-PATCH; TRANSCUTANEOUS IMMUNIZATION;

ANIMALS; ANTIBODIES; ANTIGENS; CELL MEMBRANES; COMPOSITE MICROMECHANICS; DNA; DRUG THERAPY; GENES; IMMUNIZATION; LIPOSOMES; NUCLEIC ACIDS; PHOSPHOLIPIDS; SKIN; VIRUSES;

VACCINES;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; 3 BETA [N (N,N DIMETHYLAMINOETHANE)CARBAMOYL]CHOLESTEROL; ANTIBODY; DIOLEOYPHOSPHATIDYL ETHANOLAMINE; DNA VACCINE; ENVELOPE PROTEIN; JAPANESE ENCEPHALITIS VACCINE; LIPOPLEX; LIPOSOME; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CELL ASSAY; CELL STRAIN BHK; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA IMMUNIZATION; DNA TRANSFECTION; DRUG EFFECT; EPIDEMIC ENCEPHALITIS; EPIDERMIS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; JAPANESE ENCEPHALITIS VIRUS; LIPOSOMAL DELIVERY; LIPOSOMAL GENE DELIVERY SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SPLEEN;

ADMINISTRATION, CUTANEOUS; ANIMALS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HISTOCYTOCHEMISTRY; IMMUNIZATION; KINETICS; LIPOSOMES; LUCIFERASES, RENILLA; MICE; MICE, INBRED C3H; PLASMIDS; VACCINATION; VACCINES, DNA;

EID: 63649090482     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.01.014     Document Type: Article

References (49)

1. Burke D.S., and Monath T.P. Flaviviruses. In: Knipe D.M., and Howley P.M. (Eds). Field's Virology. 4th ed (2001), Lippincott Williams & Wilkins Publishers, Philadelphia, PA 1043-1125
2. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., Kotchasenee S., Gingrich J.B., Latendresse J., and Fukai K. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319 (1988) 608-614
3. Xin Y.Y., Ming Z.G., Peng G.Y., Jian A., and Min L.H. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am. J. Trop. Med. Hyg. 39 (1988) 214-217
4. Chen H.W., Pan C.H., Liau M.Y., Jou R., Tsai C.J., and Wu H.J. Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines. J. Virol. 73 (1999) 10137-10145
5. Wu C.J., Huang H.W., and Tao M.H. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. Vaccine 21 (2003) 3938-3945
6. McDonnell W.M., and Askari F.K. DNA vaccines. N. Engl. J. Med. 334 (1996) 42-45
7. Glenn G.M., Rao M., Matyas G.R., and Alving C.R. Skin immunization made possible by cholera toxin. Nature 391 (1998) 851
8. Tang D.C., Shi Z., and Curiel D.T. Vaccination onto bare skin. Nature 388 (1997) 729-730
9. Singh R.P., Singh P., Mishra V., Prabakaran D., and Vyas S.P. Vesicular systems for non-invasive topical immunization: rational and prospects. Ind. J. Pharmacol. 34 (2002) 301-310
10. Gupta P.N., Singh P., Mishra V., Jain S., Dubey P.K., and Vyas S.P. Topical immunization: mechanistic insight and novel delivery systems. Ind. J. Biotechnol. 3 (2004) 9-21
11. Karmali P.P., and Chaudhuri A. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises. Med. Res. Rev. 27 (2007) 696-722
12. Phillips J.E., Gersbach C.A., and Garcia A.J. Virus-based gene therapy strategies for bone regeneration. Biomaterials 28 (2007) 211-229
13. Felgner P.L., Gadek T.R., Holm M., Roman R., Chan H.W., Wenz M., Northrop J.P., Ringold G.M., and Danielsen M. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 7413-7417
14. Gregoriadis G., Bacon A., Caparros-Wanderley W., and McCormack B. A role for liposomes in genetic vaccination. Vaccine 20 Suppl. 5 (2002) B1-B9
15. Chang J.S., Choi M.J., Kim T.Y., Cho S.Y., and Cheong H.S. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes. Vaccine 17 (1999) 1540-1548
16. Chang J.S., Choi M.J., Cheong H.S., and Kim K. Development of Th1-mediated CD8+ effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes. Vaccine 19 (2001) 3608-3614
17. Griffiths G.D., Bailey S.C., Hambrook J.L., and Keyte M.P. Local and systemic responses against ricin toxin promoted by toxoid or peptide vaccines alone or in liposomal formulations. Vaccine 16 (1998) 530-535
18. Lee E.H., Kim A., Oh Y.K., and Kim C.K. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26 (2005) 205-210
19. Raghavachari N., and Fahl W.E. Targeted gene delivery to skin cells in vivo: a comparative study of liposomes and polymers as delivery vehicles. J. Pharm. Sci. 91 (2002) 615-622
20. Vyas S.P., Singh R.P., Jain S., Mishra V., Mahor S., Singh P., Gupta P.N., Rawat A., and Dubey P. Non-ionic surfactant based vesicles (niosomes) for non-invasive topical genetic immunization against hepatitis B. Int. J. Pharm. 296 (2005) 80-86
21. Wu C.J., Li T.L., Huang H.W., Tao M.H., and Chan Y.L. Development of an effective Japanese encephalitis virus-specific DNA vaccine. Microbes Infect. 8 (2006) 2578-2586
22. Tseng W.C., Tang C.H., Fang T.Y., and Su L.Y. Using disaccharides to enhance in vitro and in vivo transgene expression mediated by a lipid-based gene delivery system. J. Gene Med. 9 (2007) 659-667
23. Koltover I., Salditt T., and Safinya C.R. Phase diagram, stability, and overcharging of lamellar cationic lipid-DNA self-assembled complexes. Biophys. J. 77 (1999) 915-924
24. Ross P.C., and Hui S.W. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. 6 (1999) 651-659
25. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
26. Heyes J.A., Niculescu-Duvaz D., Cooper R.G., and Springer C.J. Synthesis of novel cationic lipids: effect of structural modification on the efficiency of gene transfer. J. Med. Chem. 45 (2002) 99-114
27. Zhdanov R.I., Podobed O.V., and Vlassov V.V. Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy. Bioelectrochemistry 58 (2002) 53-64
28. Rakhmanova V.A., Pozharski E.V., and MacDonald R.C. Mechanisms of lipoplex formation: dependence of the biological properties of transfection complexes on formulation procedures. J. Membr. Biol. 200 (2004) 35-45
29. Tarahovsky Y.S., Koynova R., and MacDonald R.C. DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusion. Biophys. J. 87 (2004) 1054-1064
30. Congiu A., Pozzi D., Esposito C., Castellano C., and Mossa G. Correlation between structure and transfection efficiency: a study of DC-Chol-DOPE/DNA complexes. Colloids Surf., B Biointerfaces 36 (2004) 43-48
31. Xu Y., Hui S.W., Frederik P., and Szoka Jr. F.C. Physicochemical characterization and purification of cationic lipoplexes. Biophys. J. 77 (1999) 341-353
32. Jayaraman S.C., Ramachandran C., and Weiner N. Topical delivery of erythromycin from various formulations: an in vivo hairless mouse study. J. Pharm. Sci. 85 (1996) 1082-1084
33. Bottega R., and Epand R.M. Inhibition of protein kinase C by cationic amphiphiles. Biochemistry 31 (1992) 9025-9030
34. Barron L.G., Uyechi L.S., and Szoka Jr. F.C. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes. Gene Ther. 6 (1999) 1179-1183
35. Legendre J.Y., and Szoka Jr. F.C. Delivery of plasmid DNA into mammalian cell lines using pH-sensitive liposomes: comparison with cationic liposomes. Pharm. Res. 9 (1992) 1235-1242
36. Yu W.H., Kashani-Sabet M., Liggitt D., Moore D., Heath T.D., and Debs R.J. Topical gene delivery to murine skin. J. Invest. Dermatol. 112 (1999) 370-375
37. Kripke M.L., Munn C.G., Jeevan A., Tang J.M., and Bucana C. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145 (1990) 2833-2838
38. Enk A.H., and Katz S.I. Early molecular events in the induction phase of contact hypersensitivity. Proc. Natl. Acad. Sci. U S A. 89 (1992) 1398-1402
39. Glenn G.M., Scharton-Kersten T., and Alving C.R. Advances in vaccine delivery: transcutaneous immunisation. Expert Opin. Investig. Drugs 8 (1999) 797-805
40. Garg S., Oran A., Wajchman J., Sasaki S., Maris C.H., Kapp J.A., and Jacob J. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat. Immunol. 4 (2003) 907-912
41. Anjuère F., Martín P., Ferrero I., Fraga M.L., del Hoyo G.M., Wright N., and Ardavín C. Definition of dendritic cell subpopulations present in the spleen, Peyer's lipoplex-patches, lymph nodes, and skin of the mouse. Blood 93 (1999) 590-598
42. Xu B., Wagner N., Pham L.N., Magno V., Shan Z., Butcher E.C., and Michie S.A. Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin/PNAd, alpha4beta1 integrin/VCAM-1, and LFA-1 adhesion pathways. J. Exp. Med. 197 (2003) 1255-1267
43. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
44. Mosmann T.R., and Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46 (1989) 111-147
45. Ulmer J.B., Deck R.R., Dewitt C.M., Donnhly J.I., and Liu M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89 (1996) 59-67
46. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15 (1997) 617-648
47. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., and Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159 (1997) 3638-3647
48. Sasaki S., Sumino K., Hamajima K., Fukushima J., Ishii N., Kawamoto S., Mohri H., Kensil C.R., and Okuda K. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72 (1998) 4931-4939
49. Armengol X., and Estelrich J. Physical stability of different liposome compositions obtained by extrusion method. J. Microencapsul. 12 (1995) 523-525